Eyepoint Pharmaceuticals Inc (EYPT) — Cash Flow Reinvestment Rate
Eyepoint Pharmaceuticals Inc (EYPT) has a Cash Flow Reinvestment Rate of 0.25x as of June 2023, reinvesting $14.26 Million (capex $396.00K plus investments $13.86 Million) from operating cash flow of $57.02 Million. Explore Eyepoint Pharmaceuticals Inc capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Eyepoint Pharmaceuticals Inc Cash Flow Reinvestment Rate (2010–2023)
Historical reinvestment intensity for Eyepoint Pharmaceuticals Inc across 3 annual periods. Also explore EYPT total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Eyepoint Pharmaceuticals Inc (2010–2023)
Year-by-year capital reinvestment analysis for Eyepoint Pharmaceuticals Inc. For live market cap and broader valuation context, see Eyepoint Pharmaceuticals Inc (EYPT) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 3.63x | $6.80 Million | $1.88 Million | $3.48 Million | ▲ +727.8% |
| 2015 | 0.44x | $4.51 Million | $10.30 Million | $161.00K | ▲ +28804.5% |
| 2010 | 0.00x | $15.00K | $9.90 Million | $15.00K | — |